B. Kiviat, "Molecular Biomarkers for Cancer Detection in Blood and Bodily Fluid", Critical Reviews in Clinical Laboratory Sciences, (2006).Feng Q, Yu M, Kiviat NB: Molecular biomarkers for cancer detection in blood and bodily fluids. Crit Rev Clin Lab Sci 43, 497-560 (2006)....
But there was no significant association between treated and control samples related to the other four cancer markers and blood factors These results emphasized that DMBA-induced breast cancer in SD rat strains is a suitable model for biological studies on breast cancers....
Blood biomarkers for prostate cancer detection and prognosis Prostate cancer is the most noncutaneous malignancy diagnosed in men in the USA. The discovery of prostate-specific antigen (PSA) revolutionized prostate c... SF Shariat,JA Karam,CG Roehrborn - 《Future Oncology》 被引量: 67发表: 200...
Bloodborne markers for prostate cancer have been known for almost 70 years but many have lacked specificity. The development of the prostate-specific antigen (PSA) blood test as a surrogate marker for disease in the 1980s has revolutionized the diagnosis and management of prostate cancer. Level...
Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data Using multiple datasets from real-world evidence and completed trials, a machine learning model using routine blood and clinical data is shown to be predictive of patient response to immune...
There is a need for sensitive and specific diagnostic and prognostic molecular markers which can monitor early patterns of gene expression in non-invasive exfoliated colonocytes shed in the stool, and aggression in carcinoma cells in blood of resected colorectal cancer patients. RNA-based detection ...
An individualised risk-stratified screening for prostate cancer (PCa) would select the patients who will benefit from further investigations as well as therapy. Current detection methods suffer from low sensitivity and specificity, especially for separat
Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer Overall survival in metastatic non-small cell lung cancer is improved by immunotherapy but individual responses widely vary, and pre...
In cancer, the extent to which the disease has spread is probably the most important factor in determining patient prognosis. Hence practical and non-invasive methods are needed to identify disease stage. In a previous paper we showed how diagnostic and prognostic indices for disease progression cou...
Results: Significant correlations were found between CEA and blood Cd concentrations or between CEA and period of work under exposure. Multiple regression tests revealed also relationships between some cancer markers and the work period, and thereby the lifetime exposure to heavy metals. Duration of ...